Home › Funds › HARBOR ADVISORY CORP /MA/ › ABT

HARBOR ADVISORY CORP /MA/ position in ABT

ABBOTT LABORATORIES · Health Care

HARBOR ADVISORY CORP /MA/ reported holding 23,716 shares of ABT (ABBOTT LABORATORIES) in its Q3 2026 13F filing — a position valued at US$2.3M, representing 0.62% of its reported portfolio and ranking #38 among its reported holdings. HARBOR ADVISORY CORP /MA/ has disclosed ABT holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)23.72K sh
Reported value held$2.34M
Portfolio Weight0.62%
First reportedQ3 2023
Last changeReduce
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How HARBOR ADVISORY CORP /MA/'s ABT position evolved

HARBOR ADVISORY CORP /MA/ first disclosed a stake in ABT in Q3 2023 at 38,396 shares (US$3.7M). The position peaked in Q1 2025 at 32,343 shares, worth US$4.3M. Across 13 filings, HARBOR ADVISORY CORP /MA/ increased the stake 0 time(s), trimmed it 11 time(s) and left it unchanged 1 time(s). The most recent filing (Q3 2026) shows 23,716 shares valued at US$2.3M — a reduction of -600 shares quarter over quarter..

Quarter by quarter

QuarterSharesValueChange
Q3 2023 38.40K $3.72M New
Q4 2023 37.34K $4.11M Reduce
Q1 2024 37.04K $4.21M Reduce
Q2 2024 36.59K $3.80M Reduce
Q3 2024 34.86K $3.97M Reduce
Q4 2024 33.03K $3.74M Reduce
Q1 2025 32.34K $4.29M Reduce
Q2 2025 30.75K $4.18M Reduce
Q3 2025 28.84K $3.86M Reduce
Q4 2025 26.87K $3.37M Reduce
Q1 2026 24.32K $2.50M Reduce
Q2 2026 24.32K $2.21M Hold
Q3 2026 23.72K $2.34M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About ABT and 13F data

ABT (ABBOTT LABORATORIES) is a Health Care company. 21 other funds we track also report a position in ABT — the largest reported positions include Vanguard Group (US$22.00B), Charles Schwab Investment Management (US$5.41B), CHARLES SCHWAB INVESTMENT MANAGEMENT INC (US$5.41B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding ABT

All ABT fund holders →

FAQ

How long has HARBOR ADVISORY CORP /MA/ held ABT?

HARBOR ADVISORY CORP /MA/ has disclosed ABT holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is HARBOR ADVISORY CORP /MA/'s current position in ABT?

As of Q3 2026, HARBOR ADVISORY CORP /MA/ holds 23.72K shares of ABT (ABBOTT LABORATORIES), valued at $2.34M, representing 0.62% of its reported portfolio and ranking #38.

Has HARBOR ADVISORY CORP /MA/ been buying or selling ABT?

In the latest 13F filing (Q3 2026), HARBOR ADVISORY CORP /MA/ reduced its position in ABT. The position peaked in Q1 2025 at 32.34K shares.

Which other funds hold ABT?

Other major institutional holders of ABT include Vanguard Group, Charles Schwab Investment Management, CHARLES SCHWAB INVESTMENT MANAGEMENT INC, among 21 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.